Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Colorcon
Express Scripts
McKesson
Merck
Dow
Boehringer Ingelheim

Last Updated: August 13, 2022

Investigational Drug Information for Tiapride


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the drug development status for Tiapride?

Tiapride is an investigational drug.

There have been 5 clinical trials for Tiapride. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2009.

The most common disease conditions in clinical trials are Disease, Psychotic Disorders, and Sialorrhea. The leading clinical trial sponsors are Tirat Carmel Mental Health Center, Beersheva Mental Health Center, and Assistance Publique - Hôpitaux de Paris.

Recent Clinical Trials for Tiapride
TitleSponsorPhase
Pharmacovigilance in Gerontopsychiatric PatientsHannover Medical SchoolPhase 3
Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective PsychosisInstituto de Salud Carlos IIIPhase 3
Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective PsychosisFundación Pública Andaluza Progreso y SaludPhase 3

See all Tiapride clinical trials

Clinical Trial Summary for Tiapride

Top disease conditions for Tiapride
Top clinical trial sponsors for Tiapride

See all Tiapride clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Express Scripts
McKesson
Merck
Dow
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.